Rick E Winningham
2023 - Theravance Biopharma
In 2023, Rick E Winningham earned a total compensation of $4.3M as Chief Executive Officer at Theravance Biopharma, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $251,000 |
|---|---|
| Salary | $1,047,431 |
| Stock Awards | $3,015,100 |
| Other | $5,000 |
| Total | $4,318,531 |
Winningham received $3M in stock awards, accounting for 70% of the total pay in 2023.
Winningham also received $251K in non-equity incentive plan, $1M in salary and $5K in other compensation.
Rankings
In 2023, Rick E Winningham's compensation ranked 172nd out of 2,993 executives tracked by ExecPay. In other words, Winningham earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 172 out of 2,993 | 94th |
Division Manufacturing | 88 out of 1,640 | 95th |
Major group Chemicals And Allied Products | 54 out of 909 | 94th |
Industry group Drugs | 53 out of 872 | 94th |
Industry Pharmaceutical Preparations | 36 out of 630 | 94th |
Source: SEC filing on April 5, 2024.
Winningham's colleagues
We found two more compensation records of executives who worked with Rick E Winningham at Theravance Biopharma in 2023.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019